Objective To provide evidence‐based recommendations and expert guidance for the
management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including …

Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …

Objective To provide evidence‐based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed …

Objective To provide evidence‐based recommendations and expert guidance for the
management of systemic polyarteritis nodosa (PAN). Methods Twenty‐one clinical questions …

Objective Deficiency of adenosine deaminase 2 (DADA2) is a monogenic form of vasculitis
that can resemble polyarteritis nodosa (PAN). This study was undertaken to identify potential …

Objective To describe clinical manifestations and outcomes in patients with eosinophilic
granulomatosis with polyangiitis (EGPA) in North America. Methods Analysis of patients aged …

Polyarteritis nodosa (PAN) is a primary form of vasculitis characterized by inflammation of
primarily medium-sized arteries. Several key events have shaped the current spectrum of the …

Objective. To provide evidence-based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed …

Objective. To provide evidence-based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …

Objective. To provide evidence-based recommendations and expert guidance for the
management of systemic polyarteritis nodosa (PAN). Methods. Twenty-one clinical questions …